Gotham Asset Management, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 166 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.89 and the average weighting 0.5%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2019$68,000
-16.0%
15,842
+13.5%
0.00%0.0%
Q2 2019$81,000
-65.5%
13,952
-67.3%
0.00%
-66.7%
Q2 2016$235,000
-67.1%
42,723
-55.7%
0.00%
-62.5%
Q1 2016$715,000
-21.9%
96,406
-12.5%
0.01%
-20.0%
Q4 2015$915,000
-22.1%
110,163
+1.0%
0.01%
+11.1%
Q1 2015$1,175,000109,0800.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2015
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders